Current Report Filing (8-k)
February 22 2021 - 9:15AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) February 22, 2021 (February 21, 2021)
SRAX,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-37916
|
|
45-2925231
|
(State
or other jurisdiction
of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification No.)
|
2629
Townsgate Road #215, Westlake Village, CA
|
|
91361
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
|
|
(323)
694-9800
|
not
applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title
of Class
|
|
Trading
Symbol
|
|
Name
of Each Exchange on Which Registered
|
Class
A Common stock
|
|
SRAX
|
|
NASDAQ
Capital Market
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
1.01. Entry into a Material Definitive Agreement.
On February
21, 2021, SRAX, Inc. (the “Company”) entered into letter agreements (the “Letter Agreements”) with certain
existing institutional and accredited investors to exercise certain outstanding warrants (the “Existing Warrants”)
to purchase up to an aggregate of 4,545,550 shares of the Company’s Class A common stock (“Common Stock”)
at their original exercise price of $2.50 per share (the “Exercise”). The shares of Common Stock underlying
the Existing Warrants were previously registered pursuant to a registration statement on Form S-3 (File No. 333-240270).
In consideration for the exercise of the Existing Warrants for cash, the exercising holders will receive new registered warrants
to purchase up to an aggregate of 4,545,440 shares of Common Stock (the “New Warrants”) at an exercise
price of $7.50 per share and will expire on January 31, 2022. The New Warrants will be issued pursuant to the existing
shelf registration statement on Form S-3 (File No.333-235298). Each investor has agreed to pay $0.125 for each New Warrant received.
Pursuant
to the Letter Agreements, the New Warrants shall be substantially in the form of the Existing Warrants, will be exercisable immediately,
and will have a term that ends on January 31, 2022.
The Special Equities Group, a division of
Bradley Woods & Co. Ltd., acted as warrant solicitation agent and will receive a cash fee of $909,088.
Prior to deducting solicitation agent fees,
the Company expects to receive gross proceeds from the Exercise of $11,931,780. The Company currently intends
to use the net proceeds from the Exercise for general working capital. The closing of the Exercise is expected to take place on
or about February 23, 2022.
The
foregoing descriptions of the Letter Agreements and the New Warrants are not complete and are qualified in their entirety by reference
to the full text of the form of Letter Agreement and the form of the New Warrant, copies of which are attached as Exhibits 10.01
and 4.01, respectively, to this Current Report on Form 8-K and are incorporated by reference herein.
This
report shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification
under the securities laws of any such state or jurisdiction.
Item
9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed
on its behalf by the undersigned hereunto duly authorized.
Date:
|
February
22, 2021
|
|
SRAX,
Inc.
|
|
|
|
|
|
|
|
/s/
Christopher Miglino
|
|
|
By:
|
Christopher Miglino
|
|
|
|
Chief
Executive Officer
|
INDEX
OF EXHIBITS
SRAX (NASDAQ:SRAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SRAX (NASDAQ:SRAX)
Historical Stock Chart
From Apr 2023 to Apr 2024